March 2, 2026 · Form 4 insider transaction
Konidaris Tasos bought 72,622 shares of Amneal Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.; The restricted stock units vest in four equal annual installments beginning on March 2, 2027.